Abstract
In order to address difficulties in running RCTs, clinicians introduced the concept of a totally objective group of assessors to continually evaluate and review trial results and execution. These groups are known as Data Monitoring Committees (DMC) and have been set up to minimise trial complications while also optimizing trial implementation. Furthermore, as it quickly became apparent that the results of some trials had significant implications for patient care before trials had been completed, the DMCs who are responsible for the continual review of trial data also adopted the power to stop or advise extension of each experiment if deemed scientifically necessary. This chapter delineates the role of these committees, and also clari-fies some of their functions through some surgical trial examples.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
United States Food and Drug Administration (2001) Guidance for clinical trial sponsors: on the establishment and operation of Clinical Trial Data Monitoring Committees. Available at: http://www.fda.gov/Cber/gdlns/clindatmon.htm
Anon (1988) Organization, review, and administration of cooperative studies (Greenberg Report): a report from the Heart Special Project Committee to the National Advisory Heart Council, May 1967. Control Clin Trials 9:137–148
Anon (1973) The coronary drug project. Design, methods, and baseline results. Circulation 47:I1–50
Canner PL, Berge KG, Wenger NK et al (1986) Fifteen year mortality in Coronary Drug Project patients: long-term ben-efit with niacin. J Am Coll Cardiol 8:1245–1255
National Institutes of Health (NIH) (1998) NIH policy for data and safety monitoring. Available AT: http://grants.nih.gov/grants/guide/notice-files/not98-084.html
National Cancer Institute (1999) Policy of the national cancer institute for data and safety monitoring of clinical trials. Available at: http://deainfo.nci.nih.gov/grantspolicies/datasa-fety.htm
National Cancer Institute (2006) Guidelines for monitoring of clinical trials for Cooperative Groups, CCOP research bases, and The Clinical Trials Support Unit (CTSU). Available at: http://ctep.cancer.gov/monitoring/2006_ctmb_ guidelines.pdf
DeMets DL, Fleming TR (2004) The independent statistician for data monitoring committees. Stat Med 23: 1513–1517
Naylor AR, Bolia A, Abbott RJ et al (1998) Randomized study of carotid angioplasty and stenting versus carotid endarterectomy: a stopped trial. J Vasc Surg 28:326–334
Jackisch C, von Minckwitz G, Eidtmann H et al (2002) Dose-dense biweekly doxorubicin/docetaxel versus sequential neoadjuvant chemotherapy with doxorubicin/cyclophos-phamide/docetaxel in operable breast cancer: second interim analysis. Clin Breast Cancer 3:276–280
Chen-Mok M, Bangdiwala SI, Dominik R et al (2003) Termination of a randomized controlled trial of two vasec-tomy techniques. Control Clin Trials 24:78–84
Veronesi U, Maisonneuve P, Costa A et al (1998) Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study. Lancet 352:93–97
Anon (1994) Clinical advisory: carotid endarterectomy for patients with asymptomatic internal carotid artery stenosis. Stroke 25:2523–2524
Anon (1995) Carotid endarterectomy for patients with asymptomatic internal carotid artery stenosis. National Institute of Neurological Disorders and Stroke. J Neurol Sci 129:76–77
Buchwald H, Matts JP, Hansen BJ et al (1987) Program on surgical control of the hyperlipidemias (POSCH): recruitment experience. Control Clin Trials 8:94S–104S
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ashrafian, H., Mayer, E., Athanasiou, T. (2010). Monitoring Trial Effects. In: Athanasiou, T., Debas, H., Darzi, A. (eds) Key Topics in Surgical Research and Methodology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-71915-1_6
Download citation
DOI: https://doi.org/10.1007/978-3-540-71915-1_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-71914-4
Online ISBN: 978-3-540-71915-1
eBook Packages: MedicineMedicine (R0)